This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

5 Stocks Insiders Love Right Now

Stocks in this article: RST CRY AKAM NSPH SPWR

Cryolife

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Another stock that insiders are snapping up here is Cryolife (CRY - Get Report), which preserves and distributes human tissues for transplantation and develops, manufactures, and commercializes medical devices for cardiac and vascular applications. Insiders are buying this stock into some modest weakness since shares are off by just 3.9% so far in 2012.

Cryolife has a market cap of $127 million and an enterprise value of $108 million. This stock trades at a reasonable valuation, with a trailing price-to-earnings of 19.29 and a forward price-to-earnings of 13.56. Its estimated growth rate for this year is -62.9%, and for next year it's pegged at 161.50%. This is cash-rich company, since the total cash position on its balance sheet is $21.15 million and its total debt is zero.

A director just bought 25,000 shares, or about $119,000 worth of stock, at $4.79 per share.

From a technical perspective, CRY is currently trading below both its 50-day and 200-day moving averages, which is bearish. This stock has been downtrending for the last four months, with shares sliding lower from a high of $6.02 to a recent low of $4.19 a share. During that move, shares of CRY have consistently made lower highs and lower lows which is bearish technical price action.

>>Hot Biotech Stocks Traded by Hedge Funds

If you're in the bull camp on CRY, then I would only look for long-biased trades once it triggers a move back above its 200-day at $4.95, and then its 50-day at $4.99 a share with high-volume. Look for volume on that move that's close to or above its three-month average action of 85,523 shares. I would only be interested in CRY if it can sustain a trend above both of those key moving averages with strong upside volume flows.

On the flipside, I would avoid CRY or look for short-biased trades if it fails to trigger that move, and then drops below some near-term support at $4.40 to $4 a share with heavy volume. A move below $4 would be very bearish for CRY since it would mean the stock has entered new 52-week-low territory.

3 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,191.37 -195.84 -1.13%
S&P 500 2,002.16 -27.39 -1.35%
NASDAQ 4,637.9940 -43.5030 -0.93%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs